A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP.

Anvari, Kazem; Seilanian-Toussi, Mehdi; Hosseinzad-Ashkiki, Hossein; Shahidsales, Soodabeh

Anvari, Kazem; Seilanian-Toussi, Mehdi; Hosseinzad-Ashkiki, Hossein; Shahidsales, Soodabeh.

Afiliación

Anvari K; Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Seilanian-Toussi M; Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Hosseinzad-Ashkiki H; Dept. of Radiation Oncology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Shahidsales S; Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Iran J Cancer Prev ; 8(2): 84-8, 2015.

Article en En | MEDLINE | ID: mdl-25960846

Palabras clave

Adriamycin; Chemotherapy induced nausea and vomiting; cyclophosphamide; granisetron, metoclopramide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Iran J Cancer Prev Año: 2015 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google